Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT: Tapentadol to Prevent Chronic Postoperative Pain after Inguinal Hernia and Knee Surgery
2024-511010-21-00Phase 4Authorised
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Persistent postsurgical pain (PPSP) comparing Tapentadol prolonged-release with Placebo (2 arms). Primary endpoint: Primary. Planned start Jul 2024; status: authorised.
02
Drugs
tapentadol
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on 2024-511010-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511010-21-00.